Interstitial Cystitis

Interstitial cystitis/bladder pain syndrome (IC/BPS) is prevalent and disrupts daily life. Dietary modification is commonly recommended, but evidence is fragmented. We systematically compared dietary interventions; we hypothesized that individualized elimination may improve symptoms, but overall randomized evidence remains limited.

Repeated intravesical injections of autologous platelet-rich plasma (PRP) have shown promise in alleviating symptoms of non-ulcer interstitial cystitis bladder pain syndrome (IC/BPS), but the underlying mechanisms remain unclear.

Background/Objectives: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition characterized by pelvic pain, urinary symptoms, and reduced quality of life, with limited effective treatment options.

Painful bladder syndrome/interstitial cystitis (PBS/IC) is a chronic pelvic pain condition with unclear etiology that significantly affects quality of life. Although physiotherapeutic interventions are considered low-risk conservative options and may be incorporated into multimodal management in selected patients, evidence regarding their effectiveness remains limited.

Interstitial cystitis/bladder pain syndrome (IC/BPS) represents a chronic, non-infectious inflammatory bladder disorder, predominantly affecting women. Primary symptoms include ongoing pelvic pain, frequent urination, and urgency, often accompanied by functional somatic pain syndromes and psychological health disturbances.

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a common, stigmatizing, and poorly understood condition. With more people turning to TikTok for health information, it is important to assess the quality of IC/BPS-related content on this platform, which has not been studied to date.

Interstitial cystitis significantly affects women's overall well-being. Limited research has explored the lived experiences of women with interstitial cystitis from a qualitative perspective.

To explore the lived experiences of women diagnosed with interstitial cystitis and to understand its multidimensional impacts on daily life.

Background Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating condition of chronic pelvic pain associated with urinary frequency and comorbid anxiety and depression. Recent studies in IC/BPS patients and rodent models implicate fecal dysbiosis and increased systemic exposure to endotoxin.

Patients with interstitial cystitis/bladder pain syndrome (IC/BPS) may present with different cystoscopic bladder conditions. The current study investigated the treatment outcomes of repeated intravesical platelet-rich plasma (PRP) injections for various bladder conditions.

Bladder pain syndrome is a chronic condition characterized by bladder pain associated with other urologic symptoms. It is a diagnosis of exclusion. Initial evaluation of suspected bladder pain syndrome includes a thorough history, physical examination, urinalysis, and urine culture, with cystoscopy reserved for further assessment.